Biolife Solutions (BLFS) Receivables - Net (2016 - 2025)
Biolife Solutions (BLFS) has disclosed Receivables - Net for 16 consecutive years, with $8.0 million as the latest value for Q4 2025.
- On a quarterly basis, Receivables - Net fell 6.17% to $8.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.0 million, a 6.17% decrease, with the full-year FY2025 number at $8.0 million, down 6.17% from a year prior.
- Receivables - Net was $8.0 million for Q4 2025 at Biolife Solutions, down from $10.8 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $33.9 million in Q4 2022 to a low of $7.9 million in Q4 2023.
- A 5-year average of $19.4 million and a median of $19.4 million in 2021 define the central range for Receivables - Net.
- Peak YoY movement for Receivables - Net: soared 384.79% in 2021, then plummeted 76.73% in 2023.
- Biolife Solutions' Receivables - Net stood at $23.2 million in 2021, then soared by 46.17% to $33.9 million in 2022, then tumbled by 76.73% to $7.9 million in 2023, then increased by 7.32% to $8.5 million in 2024, then dropped by 6.17% to $8.0 million in 2025.
- Per Business Quant, the three most recent readings for BLFS's Receivables - Net are $8.0 million (Q4 2025), $10.8 million (Q3 2025), and $10.1 million (Q2 2025).